Treatment of multiple sclerosis-related trigeminal neuralgia with ...
BTX-A treatment showed efficacy in 52% of TN-MS and 45% of TN-P patients. Efficacy was higher with concomitant continuous pain and lower with prior interventional treatments.
Reference News
Treatment of multiple sclerosis-related trigeminal neuralgia with ...
BTX-A treatment showed efficacy in 52% of TN-MS and 45% of TN-P patients. Efficacy was higher with concomitant continuous pain and lower with prior interventional treatments.